Federated Hermes’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.9M | Sell |
1,248,573
-20,778
| -2% | -$981K | 0.11% | 230 |
|
|
2025
Q1 | $49.6M | Sell |
1,269,351
-10,701
| -0.8% | -$418K | 0.11% | 238 |
|
|
2024
Q4 | $69.3M | Buy |
1,280,052
+149,724
| +13% | +$8.11M | 0.15% | 182 |
|
|
2024
Q3 | $57M | Buy |
1,130,328
+1,900
| +0.2% | +$95.8K | 0.13% | 214 |
|
|
2024
Q2 | $49.6M | Buy |
1,128,428
+28,672
| +3% | +$1.26M | 0.12% | 221 |
|
|
2024
Q1 | $55.2M | Buy |
1,099,756
+39,230
| +4% | +$1.97M | 0.13% | 210 |
|
|
2023
Q4 | $64M | Sell |
1,060,526
-23,724
| -2% | -$1.43M | 0.16% | 163 |
|
|
2023
Q3 | $61.8M | Sell |
1,084,250
-85,249
| -7% | -$4.86M | 0.16% | 159 |
|
|
2023
Q2 | $59.6M | Buy |
1,169,499
+365,000
| +45% | +$18.6M | 0.15% | 175 |
|
|
2023
Q1 | $17.2M | Buy |
+804,499
| New | +$17.2M | 0.04% | 433 |
|